☆ 4.6 Article

Patient-reported Outcomes and Disability Are Associated with Histological Disease Activity in Patients with Ulcerative Colitis: Results from the APOLLO Study

JOURNAL OF CROHNS & COLITIS (2023)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

Histologic Evaluation Using the Robarts Histopathology Index in Patients With Ulcerative Colitis in Deep Remission and the Association of Histologic Remission With Risk of Relapse

Jin Park et al.

Summary: This study evaluated the risk of relapse in ulcerative colitis patients who achieved deep remission based on the status of histologic activity, showing that histologic remission was independently associated with a lower risk of clinical relapse.

INFLAMMATORY BOWEL DISEASES (2022)

Add to Collection

Article Gastroenterology & Hepatology

ECCO Position on Harmonisation of Crohn's Disease Mucosal Histopathology

F. Magro et al.

Summary: Inflammatory bowel disease (IBD) relies on mucosal healing as a significant therapeutic target and predictor of clinical course. In Crohn's disease (CD), there are limited studies on the importance of histological remission as a therapeutic target. Standardization of evaluating CD histological activity procedures is desirable. A consensus group by the European Crohn's and Colitis Organisation (ECCO) has developed position statements on CD histology to address these needs.

JOURNAL OF CROHNS & COLITIS (2022)

Add to Collection

Article Medicine, General & Internal

Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

Silvio Danese et al.

LANCET (2022)

Add to Collection

Article Gastroenterology & Hepatology

Complete endoscopic healing is associated with lower disability than partial endoscopic healing in Crohn's disease: A prospective multicenter study

Clara Yzet et al.

Summary: This study found that complete endoscopic healing (CDEIS = 0) was associated with lower disability compared to partial endoscopic healing (CDEIS >0 and <4). Partial endoscopic healing, female gender, and smoking were significantly associated with moderate to severe disability.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2022)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD

Catherine Le Berre et al.

Summary: The SPIRIT consensus group has agreed that the ultimate therapeutic goal in both CD and UC is to prevent disease impact on patients' lives, including health-related quality of life, disability, and fecal incontinence, as well as prevent complications in the short and long term, such as bowel damage, surgeries, disease extension, extraintestinal manifestations, and dysplasia or cancer. These recommendations will need to be validated in clinical studies before being implemented in disease-modification trials.

GASTROENTEROLOGY (2021)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Deep Neural Network Accurately Predicts Prognosis of Ulcerative Colitis Using Endoscopic Images

Kento Takenaka et al.

GASTROENTEROLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel Disease

Sara Tadbiri et al.

Summary: In this study, the IBD-disk score was found to be well correlated with IBD daily-life burden, demonstrating its potential for clinical use in assessing IBD-related disability. The high completion rate of the IBD-disk questionnaire suggests that it could be a valuable tool in evaluating the impact of IBD on patients' daily lives. The study also showed that an optimal cut-off of 40 for the IBD-disk score could effectively identify patients with high IBD daily-life burden.

JOURNAL OF CROHNS & COLITIS (2021)

Add to Collection

Article Gastroenterology & Hepatology

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

Dan Turner et al.

Summary: STRIDE-II presents treatment targets for both adult and pediatric IBD, including long-term and short-term goals. These targets cover aspects such as clinical response, endoscopic healing, quality of life, and growth, providing guidance for improving patient outcomes.

GASTROENTEROLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Ulcerative Colitis Narrative Global Survey Findings:The Impact of Living With Ulcerative Colitis-Patients' and Physicians' View

Marla C. Dubinsky et al.

Summary: The global patient and physician survey on Ulcerative Colitis (UC) revealed that patients experience diagnostic delay, poor disease control, and adverse impact on their quality of life. The majority of patients felt that UC controlled their life rather than them controlling their disease. Emotional and mental health issues were infrequently discussed at routine appointments by physicians, contrasting with patients' perspectives.

INFLAMMATORY BOWEL DISEASES (2021)

Add to Collection

Article Gastroenterology & Hepatology

International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey

David T. Rubin et al.

Summary: Patients and physicians with inflammatory bowel diseases generally share the same treatment goals and communication patterns, but differ in definitions of remission, expectations for treatment efficacy, and concerns about corticosteroid use.

INFLAMMATORY BOWEL DISEASES (2021)

Add to Collection

Review Gastroenterology & Hepatology

Breaking the therapeutic ceiling in drug development in ulcerative colitis

Dahham Alsoud et al.

Summary: This article discusses the limitations of therapeutic efficacy in ulcerative colitis treatment, the shortcomings of current strategies, and proposes solutions for improving therapeutic outcomes.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial

Brian G. Feagan et al.

Summary: The study assessed the efficacy and safety of filgotinib in treating ulcerative colitis, with the results showing that 200 mg of filgotinib was more effective than placebo in inducing and maintaining clinical remission.

LANCET (2021)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Evolving therapeutic goals in ulcerative colitis: towards disease clearance

Silvio Danese et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Automatic, computer-aided determination of endoscopic and histological inflammation in patients with mild to moderate ulcerative colitis based on red density

Peter Bossuyt et al.

GUT (2020)

Add to Collection

Article Gastroenterology & Hepatology

VALIDation of the IBD-Disk Instrument for Assessing Disability in Inflammatory Bowel Diseases in a French Cohort: The VALIDate Study

Catherine Le Berre et al.

JOURNAL OF CROHNS & COLITIS (2020)

Add to Collection

Article Gastroenterology & Hepatology

Correlation of Patient-Reported Outcome (PRO-2) with Endoscopic and Histological Features in Ulcerative Colitis and Crohn's Disease Patients

Sanja Dragasevic et al.

GASTROENTEROLOGY RESEARCH AND PRACTICE (2020)

Add to Collection

Article Medicine, General & Internal

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

B. E. Sands et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Review Gastroenterology & Hepatology

Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development

Walter Reinisch et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Add to Collection

Review Gastroenterology & Hepatology

Patient-Reported Outcome Measures for Use in Clinical Trials and Clinical Practice in Inflammatory Bowel Diseases: A Systematic Review

Marin J. de Jong et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Prognostic value of histological activity in patients with ulcerative colitis in deep remission: A prospective multicenter study

Triana Lobaton et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)

Add to Collection

Letter Gastroenterology & Hepatology

Prime Time Was Yesterday for Patient-reported Outcomes in Daily Care of Patients With Inflammatory Bowel Diseases

Peter Bossuyt et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Discrepancies between patient-reported outcomes, and endoscopic and histological appearance in UC

Jean-Frederic Colombel et al.

GUT (2017)

Add to Collection

Article Gastroenterology & Hepatology

Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases

Subrata Ghosh et al.

INFLAMMATORY BOWEL DISEASES (2017)

Add to Collection

Review Medicine, General & Internal

Ulcerative colitis

Ryan Ungaro et al.

LANCET (2017)

Add to Collection

Article Gastroenterology & Hepatology

Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up

Robert V. Bryant et al.

GUT (2016)

Add to Collection

© Peeref 2019-2024. All rights reserved.